title: Angiogenesis: a harmonized target for recovery after stroke.
authors.affiliation: Program in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, Augusta, GA 30912, USA.
authors.forename: Adviye
authors.initials: A
authors.lastname: Ergul
authors.forename: Ahmed
authors.initials: A
authors.lastname: Alhusban
authors.forename: Susan C
authors.initials: SC
authors.lastname: Fagan
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy / Q000473:pathology*; D005081:Exercise Therapy; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use; D018919:Neovascularization, Physiologic / Q000187:drug effects / Q000502:physiology*; D009414:Nerve Growth Factors / Q000502:physiology / Q000627:therapeutic use; D058986:Phosphodiesterase 5 Inhibitors / Q000627:therapeutic use; D026741:Physical Therapy Modalities; D020127:Recovery of Function; D020521:Stroke / Q000188:drug therapy / Q000473:pathology*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D009414:Nerve Growth Factors; D058986:Phosphodiesterase 5 Inhibitors